NCT06302842View on ClinicalTrials.gov

Pilot Open Label Study With Commercial Supplementation in Healthy Subjects

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

October 15, 2023

Study Completion Date

December 31, 2024

Conditions
Supportive Care
Interventions
DIETARY_SUPPLEMENT

Bioritmon Immuno Defend

Bioritmon Immuno Defend daily oral preparation for 24 days.

Trial Locations (1)

20145

Istituto Auxologico Italiano IRCCS, Milan

All Listed Sponsors
lead

Istituto Auxologico Italiano

OTHER